Stable Isotopes Product Detail

Sitaxsentan-13C4 Sodium

Chemical Properties and Information

Product Code: CS-T-94431 Stable Isotopes
Sitaxsentan-13C4 Sodium
API Family
Sitaxsentan
Product Code
CS-T-94431

Sitaxsentan-13C4 Sodium

Sitaxsentan Stable Isotopes
Stock Status: : Enquire Live

CAT No.
CS-T-94431
CAS No.
210421-74-2-unlabelled
Molecular Formula
C1413C4H14ClN2NaO6S2
Molecular Weight
480.86
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
210421-74-2-unlabelled
Product Code
CS-T-94431
M.F.
C1413C4H14ClN2NaO6S2
M.W.
480.86
Smiles
O=C(C(SC=C1)=C1[S](N[13C](ON=[13C]2[13CH3])=[13C]2Cl)(=O)=O)CC(C=C(OCO3)C3=C4)=C4C.[Na]
Category
Stable Isotopes
API Family
Sitaxsentan
Storage Condition
Refer MSDS for complete information.
IUPAC Name
N-(4-Chloro-3-methyl-5-isoxazolyl-13C4)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]-3-thiophenesulfonamide Sodium
References
Wu, C., et al.: J. Med. Chem., 40, 1690 (1997), Tilton, R.G., et al.: Pulm. Pharmacol. Ther., 13, 87 (2000), Horn, E.M., et al.: Expert. Opin. Invest. Drugs, 13, 1483 (2004), Langleben, D., et al.: Chest, 126, 1377 (2004),
Synonyms
IPI 1040-13C4; Sitax-13C4 ; Sitaxentan-13C4 Sodium; TBC 11251-13C4 ; Thelin-13C4
Application Notes
Labelled Sitaxsentan. Selective endothelin A (ETA) receptor antagonist. Antihypertensive. Used in treatment of chronic heart failure
Hazard Compound
Refer MSDS for complete information.
Overview
Labelled Sitaxsentan. Selective endothelin A (ETA) receptor antagonist. Antihypertensive. Used in treatment of chronic heart failure
Downloading MSDS…
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.